Quarterly rpt on consolidated results for the financial period ended 30 Jun 2026
| PHARMANIAGA BERHAD |
| Financial Year End | 31 Dec 2026 |
| Quarter | 2 Qtr |
| Quarterly report for the financial period ended | 30 Jun 2026 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
30 Jun 2026
|
30 Jun 2025
|
30 Jun 2026
|
30 Jun 2025
|
||
|
MYR'000
|
MYR'000
|
MYR'000
|
MYR'000
|
||
| 1 | Revenue |
1,041,034
|
926,864
|
2,219,558
|
1,982,213
|
| 2 | Profit/(loss) before tax |
17,807
|
7,434
|
64,217
|
52,937
|
| 3 | Profit/(loss) for the period |
13,023
|
4,213
|
45,213
|
34,461
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
12,493
|
3,960
|
43,964
|
33,539
|
| 5 | Basic earnings/(loss) per share (Subunit) |
0.95
|
0.27
|
3.35
|
2.33
|
| 6 | Proposed/Declared dividend per share (Subunit) |
0.48
|
0.00
|
1.73
|
0.00
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent |
0.3497
|
0.0663
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 13 Aug 2026 |
| Category | Financial Results |
| Reference Number | FRA-10082026-00012 |